2-Bromo-N-pyrimidin-4-yl-acetamide → (R)-3-Hydroxy-1-(pyrimidin-4-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2]octane bromide
Reaction equation
[Br-].[OH:2][C@@H:3]1[CH:8]2[CH2:9][CH2:10][N+:5]([CH2:11][C:12](=[O:19])[NH:13][C:14]3[CH:18]=[CH:17]O[N:15]=3)([CH2:6][CH2:7]2)[CH2:4]1.[Br:20]C[C:22]([NH:24]C1C=CN=CN=1)=O>>[Br-:20].[OH:2][C@@H:3]1[CH:8]2[CH2:9][CH2:10][N+:5]([CH2:11][C:12](=[O:19])[NH:13][C:14]3[CH:18]=[CH:17][N:24]=[CH:22][N:15]=3)([CH2:6][CH2:7]2)[CH2:4]1Participants
3
Procedure
This compound was prepared by an analogous method to (R)-3-Hydroxy-1-(isoxazol-3-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2]octane bromide (Intermediate A) by replacing 2-bromo-N-isoxazol-3-yl-acetamide (Ai) with 2-bromo-N-pyrimidin-4-yl-acetamide (Qi).
Sources & evidence
- ORD record
- ord-5c8de105cf5247d7ab7e599308032165
- Source dataset
- uspto-grants-2010_05
- Patent number
- US07723356B2
Reaction notes
Loading…